Furthermore, we observed significantly reduced survival in patients exhibiting low IL34 expression in cervical SCC, in head and neck SCC (HNSCC) and in lung SCC (Figure 1b–d). This evidence concerns the gene IL34 and head and neck squamous cell carcinoma.